Equity

9 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Preferred Stock

In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of December 31, 2023 and March 31, 2023, there were no shares of preferred stock issued and outstanding.

Common Stock and Creation of Dual-Class Structure

The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company’s board of directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation which authorized 1,000,000,000 shares of Class A common stock with par value of $0.001 and one vote per share, and 500,000,000 shares of Class B common stock with par value of $0.001 and ten votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company’s 85,523,836 shares of then-existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into one share of Class A common stock. As of December 31, 2023, there were 121,773,095 shares of Class A common stock, and 64,402,282 shares of Class B common stock outstanding.

Stock Repurchase Program

On May 12, 2022, the Company’s board of directors authorized a program to repurchase up to $70 million of the Company’s Class A common stock. As of September 30, 2022, the Company repurchased and retired 2,150,982 shares of Class A common stock for an aggregate purchase price of $70 million, thereby completing this share repurchase program.

On October 28, 2022, the Company’s board of directors authorized an additional program to repurchase up to $70 million of the Company’s Class A common stock over a period of 12 months. In addition, on June 1, 2023, the Company’s board of directors authorized a program to repurchase up to $200 million of the Company’s Class A common stock over a period of 24 months. As of October 2023, the Company repurchased and retired 11,639,553 shares of Class A common stock for an aggregate purchase price of $270.0 million under these repurchase programs, thereby completing these share repurchase programs.

On October 26, 2023, the Company’s board of directors authorized a program to repurchase up to $70 million of the Company’s Class A common stock over a period of 12 months. The repurchases are subject to general business and market conditions and other investment opportunities and may be executed through open market purchases or privately negotiated

transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. As of December 31, 2023, the Company repurchased and retired 331,960 shares of Class A common stock for an aggregate purchase price of $8.0 million. As of December 31, 2023, $62.0 million remained available and authorized for repurchase.

Effective January 1, 2023, the Company’s share repurchases in excess of allowable share issuances are subject to a 1% excise tax as a result of the Inflation Reduction Act of 2022. During the nine months ended December 31, 2023, the Company incurred excise taxes of $1.6 million, all of which remained unpaid as of December 31, 2023.

Common Stock Warrants

In March 2017, the Company issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.72 per share in connection with a contract signed between the Company and U.S. News & World Report, L.P., or U.S. News. The warrant expires 10 years from the date of grant. 125,000 shares with an intrinsic value of $4.0 million were exercised under the warrant during the nine months ended December 31, 2022, while the remaining 125,000 shares with an intrinsic value of $2.7 million were exercised during the nine months ended December 31, 2023.

In October 2021, the Company issued a warrant to U.S. News (the “U.S. News Warrant”) to purchase 516,000 shares of Class A common stock with an exercise price of $12.56 per share in connection with the execution of a commercial agreement with U.S. News. The U.S. News Warrant expires 10 years from the date of grant. The first tranche of the U.S. News Warrant vested on May 1, 2022 and the remainder will vest on a monthly basis over approximately 6 years. The grant-date fair value of the U.S. News Warrant was $34.7 million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $76.50, volatility of 46.9%, risk-free interest rate of 1.61%, contractual term of 10 years, and an expected dividend of 0%. The fair value of the warrant is recognized as expense in cost of revenue in the condensed consolidated statements of operations on a straight-line basis over its vesting term of 6.48 years. During the nine months ended December 31, 2023 and 2022, $4.0 million and $4.0 million was recognized as stock-based compensation expense relating to the U.S. News Warrant, respectively. As of December 31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to the unvested warrants was $22.8 million, which is expected to be recognized over the remaining vesting period of 4.25 years.

Equity Incentive Plans

The Company maintains three equity incentive plans: the 2010 Equity Incentive Plan (the “2010 Plan”), the 2021 Stock Option and Incentive Plan (the “2021 Plan”), and the 2021 Employee Stock Purchase Plan (the “ESPP”). Upon IPO, the 2021 Plan became effective and the 2010 Plan was terminated. The 2010 Plan continues to govern the terms of outstanding awards that were granted prior to the termination of the 2010 Plan. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company.

The Company granted stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. During fiscal 2018, the Company granted 4,682,582 options outside of the Plans, of which 2,044,582 options were exercised and 2,638,000 were outstanding as of December 31, 2023.

The Company has shares of common stock reserved for issuance as follows (in thousands):


			December 31, 2023
Common stock warrants			516
2010 Plan
Options outstanding			15,893
2021 Plan
Awards outstanding			2,060
Shares available for future grant			41,302
2021 ESPP			8,104
Options outstanding outside the plans			2,638
Total			70,513

Stock Options

Stock options granted generally vest over four years with service-based, performance-based, and/or market-based conditions and expire ten years from the date of grant.

Stock option activities within the Plans as well as outside of the Plans were as follows:


	Number of Shares (in thousands)	Weighted-Average Exercise Price		Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Balance, March 31, 2023	22,407	$	4.39	6.56	$	627,187
Options exercised	(3,048)	3.18
Options forfeited or expired	(828)	5.37
Balance, December 31, 2023	18,531	4.54		5.93	435,409
Vested and exercisable as of December 31, 2023	12,027	3.08		5.34	300,244
Vested and expected to vest as of December 31, 2023	18,069	4.47		5.90	425,819

The aggregate intrinsic value of options exercised during the nine months ended December 31, 2023 and 2022 was $74.7 million and $85.3 million, respectively.

As of December 31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested stock options was $24.3 million, which is expected to be recognized over a weighted-average period of 2.66 years.

The Company has not granted any stock options since the first quarter of fiscal 2022.

Restricted Stock Units (“RSUs”)

RSUs granted by the Company generally vest over four years based on continued service.

The following table summarizes RSU activity (in thousands, except per share information):


	Number of Shares	Weighted- Average Grant Date Fair Value
Unvested balance, March 31, 2023	1,951	$	40.08
Granted	863	29.41
Vested	(553)	37.96
Forfeited	(426)	42.48
Unvested balance, December 31, 2023	1,835	34.95

The total fair value of RSUs vested during the nine months ended December 31, 2023 and 2022 was $15.4 million and $7.0 million, respectively.

As of December 31, 2023, total unrecognized stock-based compensation expense, net of estimated forfeitures, related to unvested RSUs was $50.5 million, which is expected to be recognized over a weighted-average period of 2.78 years.

Performance-Based Restricted Stock Units (“PSUs”)

The PSUs have service-based and performance-based vesting conditions that are satisfied upon meeting certain financial performance targets.

The following table summarizes PSU activity (in thousands, except per share information):


	Number of Shares	Weighted- Average Grant Date Fair Value
Unvested balance, March 31, 2023	206	$	34.68
Granted	165	33.25
Vested	(78)	36.96
Forfeited	(68)	34.30
Unvested balance, December 31, 2023	225	32.94

The total fair value of PSUs vested during the nine months ended December 31, 2023 and 2022 was $1.8 million and $0.4 million, respectively.

As of December 31, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested PSUs that are probable of vesting was $1.0 million, and is expected to be recognized over a weighted-average period of 1.27 years.

Stock-Based Compensation Expense

Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands):


	Three Months Ended December 31,				Nine Months Ended December 31,
	2023		2022		2023		2022
Cost of revenue	$	2,466	$	2,695	$	7,205	$	7,209
Research and development	3,080		4,002		8,874		9,416
Sales and marketing	4,060		4,856		12,752		11,912
General and administrative	2,165		2,431		6,742		6,306
Restructuring	—		—		3,646		—
Total stock-based compensation expense	$	11,771	$	13,984	$	39,219	$	34,843